Publication» Go to news main
Precision Dosimetry in Yttrium‑90 Radioembolization through CT Imaging of Radiopaque Microspheres in a Rabbit Liver Model
A new publication from Dr. George Mawko, Dr. Kimberly Brewer and Dr. Robert Abraham!
To perform precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model, and to compare extracted dose metrics to those produced from conventional PET-based dosimetry.
Materials and Methods
A CT calibration phantom was designed to contain posts having nominal microsphere concentrations of 0.5 mg/mL, 5.0 mg/mL, and 25.0 mg/mL. The mean Hounsfield unit was extracted from the post volumes to generate a calibration curve to relate Hounsfield units to microsphere concentration. A nominal bolus of 40 mg of microspheres was administered to the livers of 8 rabbits followed by PET/CT imaging. A CT-based activity distribution was calculated through the application of the calibration curve to the CT liver volume. Post-treatment dosimetry was performed through the convolution of yttrium-90 dose-voxel kernels and the PET- and CT-based cumulated activity distributions. The mean dose to the liver in PET- and CT-based dose distributions was compared through linear regression, ANOVA, and Bland-Altman analysis.
A linear least-squares fit to the average Hounsfield unit and microsphere concentration data in the calibration phantom confirmed a strong correlation (r2 > 0.999) with a slope of 14.13 HU/mg/mL. A poor correlation was found between the mean dose derived from CT and PET (r2 = 0.374) while the ANOVA analysis revealed statistically significant differences (p < 10–12) between the MIRD-derived mean dose and the PET- and CT-derived mean dose. Bland-Altman analysis predicted an offset of 15.0 Gy between the mean dose in CT and PET. The dose within the liver was shown to be more heterogeneous in CT than in PET with an average coefficient of variation equal to 1.99 and 1.02, respectively.
The benefits of a CT-based approach to post-treatment dosimetry in yttrium-90 radioembolization include improved visualization of the dose distribution, reduced partial volume effects, a better representation of dose heterogeneity, and the mitigation of respiratory motion effects. Post-treatment CT imaging of radiopaque microspheres in yttrium-90 radioembolization provides the means to perform precision dosimetry and extract accurate dose metrics used to refine the understanding of the dose-response relationship, which can permit an individualized approach to treatment planning that translates into improved patient outcomes.
Radioembolization, Yttrium-90, Radiopacity, Microsphere, Dosimetry, PET, CT
- Just published! Surgical or Endovascular Treatment of MCA Aneurysms: An Agreement Study
- Just published! Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline
- Just published! Preparedness of Residents and Medical Students for the Transition to Competence by Design in Diagnostic Radiology Post‑Graduate Medical Education
- Just published! Systematic Review of Diffuse Hemispheric Glioma, H3 G34‑mutant: Outcomes and Associated Clinical Factors
- Just published! Inaugural Pan‑Canadian RADGames: Results From a Successful Approach to Radiology Education for Medical Students
- Just published! Canadian Association of Radiologists Prostate MRI White Paper
- Publication: Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN)
- Publication: MR Imaging of Pediatric Low‑Grade Gliomas: Pretherapeutic Differentiation of BRAF V600E Mutation, BRAF Fusion, and Wild‑Type Tumors in Patients without Neurofibromatosis‑1
comments powered by Disqus